Conducting the first-ever, large-scale analysis of Pharmacy First consultations in GP records, researchers at the Bennett Institute for Applied Data Science, London School of Hygiene and Tropical Medicine, University of Nottingham, University of Manchester, and UKHSA used OpenSAFELY to analyse the programme\u2019s service uptake, data quality, and integration into primary care systems.
A clinical study at the University of Oxford has recruited its first participant, marking the world\u2019s first successful transplantation of a perfused human pancreas and a major advance in efforts to improve organ preservation for transplantation.
The European Patent Office (EPO) has awarded Professor Sir Adrian Hill the European Inventor Award 2026 in the Research category for developing the R21/Matrix-M malaria vaccine.
The Sagittarius Team, a pioneering partnership between the University of Oxford and Oxford University Hospitals (OUH) has been recognised with the OUH Award for Excellence 2026 for transforming care for people experiencing a relapse of ulcerative colitis while advancing translational research.
Patient enrolment has begun in the Democratic Republic of the Congo for the PARTNERS clinical trial of treatments for Bundibugyo virus disease (BVD). The trial is led in the DRC by the Institute National pour la Recherche Biomedicale, supported by the Institute of Tropical Medicine in Belgium, Ministry of Public Health of the Democratic Republic of the Congo, ALIMA (The Alliance for International Medical Action) and outbreak response teams from M\u00e9decins Sans Fronti\u00e8res (MSF). \r\n\r\nInternational trial coordination is led by the Pandemic Sciences Institute at the University of Oxford.
A major new research and engagement programme at the University of Oxford will investigate how healthier, more sustainable diets can be achieved at population level, and how evidence can inform policy and practice across food, health and environmental systems.
Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK\u2019s Advanced Research and Invention Agency (ARIA).
Researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, have developed a new calculator that estimates a person's risk of developing serious muscle disorders\u202ffrom statins. The tool could\u202fhelp patients and clinicians make more\u202finformed decisions about using these widely prescribed medications to prevent heart attacks and strokes.
Mr Keaton Jones, Senior Clinical Researcher at the Nuffield Department of Surgical Sciences, attended 'Driving Treatment Breakthroughs', a Pancreatic Cancer UK parliamentary reception held at the House of Commons on 16 June 2026.
The University of Oxford and King\u2019s College London (King\u2019s) have joined the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international collaboration of sites working together to accelerate clinical trial readiness and therapeutic development for autism through a large-scale natural history and clinical endpoint study.
Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found that a naturally occurring compound called spermidine may help improve vaccine responses in some older adults by reducing signs of immune system ageing.
The first study of England's harmonised education tariff finds equal funding has expanded GP placements and strengthened teaching quality \u2013 and identifies what must be protected as NHS England's functions transfer to the Department of Health and Social Care.
The largest and longest clinical trial of its kind has found that resurfacing the kneecap during total knee replacement is likely to be the most cost-effective approach for patients and healthcare systems over the long term.
The University of Oxford is set to launch a new research centre dedicated to women\u2019s mental health, bringing together expertise from medical and biological sciences with humanities for the first time.
This week the UK government announced a ban on social media for under-16s and new age limits on romantic and sexual AI chatbots, following the precedent set by Australia. Researchers from the University of Oxford's Department of Psychiatry welcome the focus on children's online safety, but argue that age limits alone are a limited safeguard, and that protecting children depends more on how platforms and AI systems are designed than on who can reach them.
Oxford Cancer is delighted to announce the appointment of Professor Adam Mead as Director, joining Professors Mark Middleton and Tim Elliott in leading Oxford\u2019s interdisciplinary cancer research community.
A new study led by Professor Geoff Higgins at the Department of Oncology, in collaboration with Artios Pharma, has uncovered a genetic vulnerability that could help identify patients most likely to benefit from a promising radiotherapy combination treatment. Published today in Science Advances, the research identifies loss of SHLD2 as a predictive biomarker for treatment with DNA polymerase theta (Pol\u03b8) inhibitors, an emerging class of DNA repair-targeted drugs.
![\"Two](\"https://www.medsci.ox.ac.uk/news/researchers-use-opensafely-to-deliver-first-ever-large-scale-analysis-of-pharmacy-first-consultations-in-gp-clinical-systems/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n